240
Participants
Start Date
April 30, 2011
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Detemir
"Subjects randomized to insulin detemir treatment group will receive the basal insulin in a 3 mL. Flex Pen® containing 300 units of insulin. insulin detemir once daily administered with the evening meal (dinner) or at bedtime as add-on to their oral antihyperglycemia (see inclusion/exclusion criteria) meds throughout the 24 week treatment period. The goal of insulin therapy is to achieve near normoglycemia with a low rate of hypoglycaemic episodes.~Insulin injections will be given subcutaneously preferably in the thigh or abdomen."
Vanderbilt University, Nashville
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Vanderbilt University
OTHER